An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming ...

The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

Here's what to know about glioblastoma, one of the most complex, deadly and treatment-resistant brain cancers.

AI-assisted interpretation of brain scans may help improve care for children with brain tumors called gliomas, which are typically treatable but vary in risk of recurrence. Investigators from Mass ...

There is currently no FDA-approved targeted amino acid PET agent for brain cancer imaging ... use of TLX101-CDx with PET for imaging progressive or recurrent glioma.